help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vänttinen, T.
Right arrow Articles by Voutilainen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vänttinen, T.
Right arrow Articles by Voutilainen, R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HYDROCORTISONE
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 9 4257-4263
Copyright © 2002 by The Endocrine Society


Other Original Article

Expression of Activin/Inhibin Receptor and Binding Protein Genes and Regulation of Activin/Inhibin Peptide Secretion in Human Adrenocortical Cells

Teemu Vänttinen, Tiina Kuulasmaa, Jianqi Liu and Raimo Voutilainen

Department of Pediatrics (T.V., T.K., R.V.), Kuopio University and University Hospital, Kuopio FIN-70211, Finland; and Department of Pathology (J.L., R.V.), Haartman-Institute, University of Helsinki, Helsinki FIN-00014, Finland

Address all correspondence and requests for reprints to: Raimo Voutilainen, M.D., Department of Pediatrics, Kuopio University Hospital, P.O. Box 1777, FIN-70211 Kuopio, Finland. E-mail: . raimo.voutilainen{at}uku.fi

Abstract

Activins and inhibins are glycoprotein hormones produced mainly in gonads but also in other organs. They are believed to be important para/autocrine regulators of various cell functions. We investigated activin/inhibin receptor and binding protein gene expression and the regulation of activin/inhibin secretion in human adrenal cells. RT-PCR revealed inhibin/activin {alpha}-, ßA/B-subunit, follistatin, activin type I/II receptor, and inhibin receptor (betaglycan and inhibin-binding protein) mRNA expression in fetal and adult adrenals and cultured adrenocortical cells. Cultured cells secreted activin A and inhibin A/B as determined by specific ELISAs. ACTH stimulated inhibin A/B secretion in fetal (1.8- and 1.8-fold of control, respectively) and in adult cells (3.4- and 1.7-fold of control, respectively) without significant effect on activin A. 8-bromoadenosine cAMP (protein kinase A activator) increased activin A and inhibin A/B secretion in the human adrenocortical NCI-H295R cell line (32-, 17-, and 3-fold of control, respectively). 12-O-tetradecanoyl phorbol-13-acetate (protein kinase C activator) stimulated both activin A and inhibin A secretion (764- and 32-fold of control, respectively), and activin treatment increased inhibin B secretion in these cells (25-fold of control). In conclusion, human adrenocortical cells produce dimeric activins and inhibins. ACTH stimulates inhibin secretion and decreases activin/inhibin secretion ratio, probably via the protein kinase A signal transduction pathway. This, together with the adrenocortical activin/ inhibin receptor and binding protein expression, suggests a physiological role for activins and inhibins in the human adrenal gland.




This article has been cited by other articles:


Home page
ReproductionHome page
K Rae, K Hollebone, V Chetty, D Clausen, and J McFarlane
Follistatin serum concentrations during full-term labour in women significant differences between spontaneous and induced labour
Reproduction, November 1, 2007; 134(5): 705 - 711.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. G. Farnworth, Y. Wang, R. Escalona, P. Leembruggen, G. T. Ooi, and J. K. Findlay
Transforming Growth Factor-{beta} Blocks Inhibin Binding to Different Target Cell Types in a Context-Dependent Manner through Dual Mechanisms Involving Betaglycan
Endocrinology, November 1, 2007; 148(11): 5355 - 5368.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. G. Farnworth, P. G. Stanton, Y. Wang, R. Escalona, J. K. Findlay, and G. T. Ooi
Inhibins Differentially Antagonize Activin and Bone Morphogenetic Protein Action in a Mouse Adrenocortical Cell Line
Endocrinology, July 1, 2006; 147(7): 3462 - 3471.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P. G Farnworth, Y. Wang, P. Leembruggen, G. T Ooi, C. Harrison, D. M Robertson, and J. K Findlay
Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins.
J. Endocrinol., March 1, 2006; 188(3): 451 - 465.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P. Utriainen, J. Liu, T. Kuulasmaa, and R. Voutilainen
Inhibition of DNA methylation increases follistatin expression and secretion in the human adrenocortical cell line NCI-H295R
J. Endocrinol., February 1, 2006; 188(2): 305 - 310.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
D. J Keating and C. Chen
Activin A stimulates catecholamine secretion from rat adrenal chromaffin cells: a new physiological mechanism
J. Endocrinol., August 1, 2005; 186(2): R1 - R5.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Yang, C. Zhong, B. Frenkel, A. H. Reddi, and P. Roy-Burman
Diverse Biological Effect and Smad Signaling of Bone Morphogenetic Protein 7 in Prostate Tumor Cells
Cancer Res., July 1, 2005; 65(13): 5769 - 5777.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C A Longui, S H V Lemos-Marini, B Figueiredo, B B Mendonca, M Castro, R Liberatore Jr, C Watanabe, C L P Lancellotti, M N Rocha, M B Melo, et al.
Inhibin {alpha}-subunit (INHA) gene and locus changes in paediatric adrenocortical tumours from TP53 R337H mutation heterozygote carriers
J. Med. Genet., May 1, 2004; 41(5): 354 - 359.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Suzuki, F. Otsuka, K. Inagaki, M. Takeda, T. Ogura, and H. Makino
Novel Action of Activin and Bone Morphogenetic Protein in Regulating Aldosterone Production by Human Adrenocortical Cells
Endocrinology, February 1, 2004; 145(2): 639 - 649.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Bertherat, L. Groussin, F. Sandrini, L. Matyakhina, T. Bei, S. Stergiopoulos, T. Papageorgiou, I. Bourdeau, L. S. Kirschner, C. Vincent-Dejean, et al.
Molecular and Functional Analysis of PRKAR1A and its Locus (17q22-24) in Sporadic Adrenocortical Tumors: 17q Losses, Somatic Mutations, and Protein Kinase A Expression and Activity
Cancer Res., September 1, 2003; 63(17): 5308 - 5319.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. D. Carpenter, K. Hayashi, and T. E. Spencer
Ovarian Regulation of Endometrial Gland Morphogenesis and Activin-Follistatin System in the Neonatal Ovine Uterus
Biol Reprod, September 1, 2003; 69(3): 851 - 860.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society